Dexamethasone May Prevent Severe AKI in COVID-19 Cases
Inhaled nitric oxide appears to increase the risk for severe acute kidney injury among ICU patients with COVID-19, a French study suggests.
Inhaled nitric oxide appears to increase the risk for severe acute kidney injury among ICU patients with COVID-19, a French study suggests.
Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events.
In a previous US phase 2 trial, no clear dose response was observed with difelikefalin.
Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.
Study findings suggest the nephroprotective effects of both drug classes are complementary.
Study findings highlight an “unmet need” for newer therapies.
Adverse effects of induction therapies for lupus nephritis may limit their use.
Colchicine, a plant-derived alkaloid, has a broad range of anti-inflammatory effects that interfere with neutrophil function, according to investigators.
New study is the first to examine the effect of the use of renin-angiotensin-aldosterone system inhibitors on AKI in COVID-19.
In a study of patients with CKD and/or heart failure on RAASi therapy, the proportion of patients who received dose reductions or had therapy discontinued after new-onset hyperkalemia increased with hyperkalemia severity.